Todd MBA - Femasys Chief Advisor
| FEMY Stock | USD 1.10 0.05 4.76% |
Insider
Todd MBA is Chief Advisor of Femasys
| Age | 56 |
| Address | 3950 Johns Creek Court, Suwanee, GA, United States, 30024 |
| Phone | 770 500 3910 |
| Web | https://www.femasys.com |
Femasys Management Efficiency
The company has return on total asset (ROA) of (0.5954) % which means that it has lost $0.5954 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3837) %, meaning that it created substantial loss on money invested by shareholders. Femasys' management efficiency ratios could be used to measure how well Femasys manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sudish Mogli | Healthcare Triangle | 55 | |
| MD MBA | Nutex Health | 51 | |
| Jon Bates | Nutex Health | 54 | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Daniel Tan | EUDA Health Holdings | 43 | |
| Richard Brounstein | Heartbeam | 74 | |
| Vivian MBA | Nutex Health | N/A | |
| Suresh Venkatachari | Healthcare Triangle | 57 | |
| John Lorbiecki | Aclarion | 61 | |
| Jon Hunt | Heartbeam | 68 | |
| Michael Gill | Healthcare Triangle | 46 | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
| FACC MD | Heartbeam | 65 | |
| Ryan Bond | Aclarion | 52 | |
| Wei Chen | EUDA Health Holdings | 39 | |
| BSN JD | Nutex Health | N/A | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Elizabeth Hall | Nutex Health | N/A | |
| Ken Persen | Heartbeam | N/A | |
| Lawrence FACS | Nutex Health | 75 | |
Management Performance
| Return On Equity | -1.38 | ||||
| Return On Asset | -0.6 |
Femasys Leadership Team
Elected by the shareholders, the Femasys' board of directors comprises two types of representatives: Femasys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Femasys. The board's role is to monitor Femasys' management team and ensure that shareholders' interests are well served. Femasys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Femasys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Damon, VP Devel | ||
| James MD, Chief Officer | ||
| Richard Spector, Chief Officer | ||
| Kathy LeeSepsick, President, Founder | ||
| Christine Thomas, Senior Affairs | ||
| Dov Elefant, Chief Officer | ||
| Todd MBA, Chief Advisor | ||
| Daniel Currie, Senior COO | ||
| MS MD, Chief Advisor | ||
| Kathy MBA, President Founder | ||
| Edward MD, Chief Officer | ||
| Mary JD, Vice Property | ||
| Sue Owens, Vice Sales | ||
| Naomi Phaneuf, Vice Marketing |
Femasys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Femasys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.38 | ||||
| Return On Asset | -0.6 | ||||
| Operating Margin | (20.24) % | ||||
| Current Valuation | 23.67 M | ||||
| Shares Outstanding | 22.9 M | ||||
| Shares Owned By Insiders | 7.60 % | ||||
| Shares Owned By Institutions | 7.25 % | ||||
| Number Of Shares Shorted | 526.65 K | ||||
| Price To Earning | 4.67 X | ||||
| Price To Book | 4.03 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Femasys Stock Analysis
When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.